Pharmaceutical Giants Brace for Revenue Plunge as Blockbuster Drug Patents Near Expiry
As the top 20 biopharma companies collectively have a staggering $180 billion in sales at risk due to patent expiration slated to occur arou
top of page
Industry News
- Jan 19
- 3 min
A Clinical Trial Showed that a TCM Product Reduced Heart Failure Hospitalizations
The TCM qiliqiangxin reduces hospitalization for heart failure and cardiovascular death in patients with heart fail
- Jan 16
- 3 min
A plant-based, oral delivery of insulin regulates blood sugar levels similar to natural insulin
A plant-based, oral delivery of proinsulin lowers the risk of hypoglycemia when compared to current diabetes treatments, according to a new
- Jan 13
- 2 min
British American Tobacco Invests $10 Million in the Hemp Industry to Develop Botanical Drugs
British American Tobacco (BAT), a major player in the global cigarette market, made a surprising move by announcing a significant...
- Dec 31, 2023
- 2 min
Chiesi Global Rare Diseases Announces FDA Approval of FILSUVEZ® for Epidermolysis Bullosa Wounds
FDA has granted approval for FILSUVEZ®, a topical gel containing birch triterpenes, designed to address the treatment of partial thickness w
- Dec 15, 2023
- 2 min
ABDA Partnership Launches Digital HPLC Database to Elevate Botanical Drug Standards
The American Botanical Drug Association (ABDA) is advancing an unprecedented initiative through its affiliated analytical laboratory,...
- Dec 11, 2023
- 1 min
Maye Musk Inspires at a Hong Kong Entrepreneur Event
Maye Musk, the renowned model, dietitian, and mother of entrepreneur Elon Musk, added star power to a high-profile entrepreneur gathering by
- Nov 15, 2023
- 2 min
OnTarget Study Innovates Cancer Therapy-Related Diarrhea Management with Crofelemer
Napo Pharmaceuticals's pivotal phase 3 OnTarget trial for prophylaxis of diarrhea in adult cancer patients is a 12-week trial targets cancer
- Oct 26, 2023
- 2 min
FDA Approves NexoBrid, a Revolutionary Topical Gel for Burn Care
In what is being hailed as a major advancement in the field of burn care, the U.S. Food and Drug Administration (FDA) has recently...
- Oct 25, 2023
- 2 min
RCT: Traditional Chinese Medicine Compound (Tongxinluo) for Acute Myocardial Infarction
In patients with ST-segment elevation myocardial infarction (STEMI), the traditional Chinese medicine Tongxinluo, as an adjunctive therapy
- Sep 26, 2023
- 1 min
Botanical Drug for the Treatment of Alopecia Areata in Children
At the forefront of groundbreaking research, Coacillium, a plant-based drug developed by Legacy Healthcare, has emerged as a potential...
- Aug 31, 2023
- 8 min
Botanical drug clinical trial: common issues and future options
Abstract: botanical drug clinical trials registered at ClinicalTrial.gov were analyzed. Trends in current trials were discovered and guide f
- Jul 21, 2023
- 2 min
Alphyn Biologics Phase 2a Trial for Atopic Dermatitis with Secondary Bacterial Infection
Alphyn Biologics, a clinical-stage dermatology company developing first-in-class Multi-Target Therapeutics, released interim results...
- Jul 21, 2023
- 1 min
Sinoveda's Botanical Drug Approach to Treat Long Covid
Sinoveda is a health brand that is bringing innovative, herbally-based precision to drug discovery. The company's research team, led by...
- Jul 15, 2023
- 1 min
CASE STUDY: Mytesi
A showcase of the first botanical drug approved by the US FDA for treating diarrheal caused by HIV/AIDS antiretroviral therapy, about the wh
- Jul 12, 2023
- 2 min
Napo Pharmaceuticals Submits Investigational New Drug (IND) Application to FDA
Napo Pharmaceuticals Inc announced the submission of an IND application to the U.S. FDA for a new crofelemer powder for oral solution formul
- Jun 10, 2023
- 2 min
Baptist University Advanced a Botanical Drug to Phase I
Hong Kong Baptist University is set to conduct the first phase of clinical trials for a novel Chinese medicine targeting chronic constipatio
- Jun 8, 2022
- 1 min
REHEVA BIOSCIENCES ANNOUNCES FIRST PATIENT ENROLLED IN RH324 PHASE I SAFETY TRIAL
ReHeva Biosciences is announcing the first patient enrolled and dosed in the Phase I Safety Trial for the company's drug, RH324.
- Nov 22, 2021
- 1 min
Paper: Coronavirus disease 2019: The prospect for botanical drug’s polymolecular approach
by Dr. Andre Boultet, Chairman and CEO of Devonian Health Group, Canada's largest botanical drug company ABSTRACT Coronavirus disease...
- Sep 27, 2021
- 1 min
A public known TCM formula opens phase 1 enrollment for US FDA botanical drug IND
In 2020, a joined force by UCLA, USC, UCSD was formed to develop scientific data on a well-known Chinese herbal medicine formula, Qing...
bottom of page